A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.

Hepatitis

Key Findings

These findings suggest that this cannabinoid derivative is an immunomodulator that could be developed as a potential drug for hepatitis as well as for other short- or long-term inflammatory diseases.

Information and Links


Link: A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.

Year: 2003


Ratings

(How Ratings Work)

Hepatitis — 2


Possible to probable range of efficacy of cannabis for treatment of Hepatitis according to the results found in this study.

Drugs Used

PRS-211,092